<?xml version="1.0" encoding="UTF-8"?>
<ref id="B24">
 <mixed-citation publication-type="journal">
  <name>
   <surname>Coelmont</surname>
   <given-names>L</given-names>
  </name>
  <name>
   <surname>Kaptein</surname>
   <given-names>S</given-names>
  </name>
  <name>
   <surname>Paeshuyse</surname>
   <given-names>J</given-names>
  </name>
  <name>
   <surname>Vliegen</surname>
   <given-names>I</given-names>
  </name>
  <name>
   <surname>Dumont</surname>
   <given-names>JM</given-names>
  </name>
  <name>
   <surname>Vuagniaux</surname>
   <given-names>G</given-names>
  </name>
  <name>
   <surname>Neyts</surname>
   <given-names>J</given-names>
  </name>
  <article-title>Debio 025, a cyclophilin binding molecule, is highly efficient in clearing hepatitis C virus (HCV) replicon-containing cells when used alone or in combination with specifically targeted antiviral therapy for HCV (STAT-C) inhibitors</article-title>
  <source>Antimicrob Agents Chemother</source>
  <year>2009</year>
  <volume>53</volume>
  <fpage>967</fpage>
  <lpage>976</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.00939-08</pub-id>
  <pub-id pub-id-type="pmid">19104013</pub-id>
 </mixed-citation>
</ref>
